Metypred

Methylprednisolone, the active ingredient in Metypred, is a glucocorticoid presented as an oral tablet for systemic use. It is employed to treat inflammatory and autoimmune disorders in adults and children when prescribed by a healthcare professional.

GNH USA supplies Metypred as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metypred is a glucocorticoid that modulates inflammatory and immune pathways across several disease groups.

- Rheumatoid arthritis: reduces joint inflammation, pain, and swelling. - Systemic lupus erythematosus: suppresses systemic immune activity and organ inflammation. - Severe asthma: decreases airway inflammation and improves breathing. - Allergic reactions: mitigates severe hypersensitivity symptoms. - Dermatologic inflammatory conditions: alleviates skin inflammation such as eczema or psoriasis. - Multiple sclerosis exacerbations: shortens relapse duration and severity.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Increased appetite or weight gain. - Elevated blood glucose levels. - Mood changes, including anxiety or insomnia. - Gastrointestinal discomfort or ulcer risk. - Fluid retention causing swelling. - Mild skin thinning or bruising.

Serious or Rare Side Effects: - Severe infections or opportunistic pathogens. - Adrenal insufficiency on abrupt discontinuation. - Osteonecrosis of the hip or jaw. - Vision problems such as cataracts or glaucoma. - Severe psychiatric disturbances, including psychosis. - Thromboembolic events.

Before initiating therapy, consider the following safety measures.

- Assess infection risk: evaluate for active infections and vaccinate appropriately. - Monitor glucose: check blood sugar in diabetic or at‑risk patients. - Screen bone health: consider calcium/vitamin D supplementation and bone density testing. - Review psychiatric history: observe for mood or psychotic changes. - Evaluate cardiovascular status: monitor blood pressure and fluid balance. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Methylprednisolone may interact with several drug classes; vigilance is required.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase systemic exposure. - Live vaccines: risk of uncontrolled infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened gastrointestinal ulcer risk. - Anticoagulants (warfarin): potential for enhanced anticoagulant effect. - Diabetic agents (insulin, oral hypoglycemics): may require dose adjustment due to hyperglycemia. - Antihypertensives: possible reduction in blood pressure‑lowering efficacy.